References:
1.Højlund M, Kemp A, Haddad PM, et al. Standard versus reduced dose of anti psychotics for relapse prevention in multiepisode schizophrenia: a systematic review and meta-analysis of randomized controlled trials. Lancet Psych 2021; 8: 471–486.
2.Ostuzzi G, Vita G, Bertolini F, et al. Continuing, reducing, switching, or stopping anti psychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis. Lancet Psych 2022; 9: 614–624.
3.Leucht S, Bauer S, Siafis S, et al. Examination of dosing of antipsychotic drugs for relapse prevention in patients with stable schizophrenia: a meta-analysis. JAMA Psychiatry 2021; 78: 1238–1248.
